OMOP Concept 36927195
upadacitinib 45 MG Extended Release Oral Tablet [Rinvoq] by Abbvie
StandardDrugRxNorm ExtensionOMOP5192496Marketed Product
Maps from
1
Descendants
0
Valid from
22 May 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
1 source code normalizes to upadacitinib 45 MG Extended Release Oral Tablet [Rinvoq] by Abbvie via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| dm+d | 41085811000001102 | Rinvoq 45mg modified-release tablets | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(18)Roll up to these when you need a wider cohort.
- 1upadacitinib 45 MG Extended Release Oral Tablet
- 1upadacitinib 45 MG Extended Release Oral Tablet [Rinvoq]
- 2Rinvoq Oral Product
- 2Rinvoq Pill
- 2upadacitinib 45 MG
- 2upadacitinib 45 MG [Rinvoq]
- 2upadacitinib Extended Release Oral Tablet
- 2upadacitinib Extended Release Oral Tablet [Rinvoq]
- 2upadacitinib Oral Product
- 2upadacitinib Pill
- 3Oral Product
- 3Pill
- 3upadacitinib
- 3upadacitinib; oral
- 4Janus-associated kinase (JAK) inhibitors
- 5IMMUNOSUPPRESSANTS
- 6IMMUNOSUPPRESSANTS
- 7ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Get this concept via the API
Resolve upadacitinib 45 MG Extended Release Oral Tablet [Rinvoq] by Abbvie - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/36927195?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card